Literature DB >> 1897013

Hepatic microcirculatory disturbances due to portal vein clamping in the orthotopic rat liver transplantation model.

I Marzi1, J Knee, M D Menger, G Harbauer, V Bühren.   

Abstract

Most modifications and applications of the orthotopic rat liver transplantation (ORLT) model require clamping of the portal vein, thus leading to ischemia of the gut. The purpose of this study was to evaluate the effect of portal vein clamping during ORLT on hepatic microcirculation and leukocyte--endothelial interaction by intravital fluorescence microscopy. ORLT were performed following 1 hr of cold storage in EuroCollins solution without (standard group) and with insertion of a portojugular shunt (shunt group) to minimize intestinal ischemia. ORLT induced reduction of perfused sinusoids (83%) and velocity of leukocytes (311 +/- 4.5 microns/sec; mean +/- SEM) compared with nontransplanted controls (99% and 417 +/- 4.9 microns/sec). Portojugular shunt during ORLT improved hepatic microvascular perfusion (89% and 355 +/- 3.4 microns/sec; P less than 0.05). Furthermore, percentage of permanent and temporary adherent leukocytes decreased significantly when a portosystemic shunt was applied (from 33.5 +/- 1% to 22.1 +/- 1% and 19.7 +/- 1.2% to 14.0 +/- 0.9%; P less than 0.05). The results of the study reveal that intestinal congestion and reperfusion results in a rise in leukocyte adhesion to the sinusoidal wall and in disturbances of the hepatic microcirculation. It seems likely that increased endotoxin concentrations in the portal vein induce an activation of hepatic macrophages that subsequently cause release of chemoattractant mediators. In conclusion, side effects of intestinal ischemia during experimental liver transplantation surgery on liver function due to release of chemoattractant mediators should be considered when experimental data are transferred to clinical settings.

Entities:  

Mesh:

Year:  1991        PMID: 1897013     DOI: 10.1097/00007890-199109000-00007

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  7 in total

Review 1.  Protection of the liver during hepatic surgery.

Authors:  Pierre-Alain Clavien; Jean Emond; Jean Nicolas Vauthey; Jacques Belghiti; Ravi S Chari; Steven M Strasberg
Journal:  J Gastrointest Surg       Date:  2004 Mar-Apr       Impact factor: 3.452

2.  Measurements of tissue viability in transplantation.

Authors:  M S Thorniley; S Simpkin; E Balogun; K Khaw; C Shurey; K Burton; C J Green
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-06-29       Impact factor: 6.237

3.  Signs of reperfusion injury following CO2 pneumoperitoneum: an in vivo microscopy study.

Authors:  Arash Nickkholgh; Miriam Barro-Bejarano; Rui Liang; Markus Zorn; Arianeb Mehrabi; Martha-Maria Gebhard; Markus W Büchler; Carsten N Gutt; Peter Schemmer
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 4.584

4.  Physiologic study of bile salt and lipid secretion in rats after liver transplantation.

Authors:  H S Xu; J A Pilcher; R S Jones
Journal:  Ann Surg       Date:  1993-04       Impact factor: 12.969

5.  Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation.

Authors:  H S Xu; L K Rosenlof; T L Pruett; R S Jones
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

6.  The effect of blood cells retained in rat livers during static cold storage on viability outcomes during normothermic machine perfusion.

Authors:  Omar Haque; Casie A Pendexter; Benjamin T Wilks; Ehab O A Hafiz; James F Markmann; Korkut Uygun; Heidi Yeh; Shannon N Tessier
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

Review 7.  Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation.

Authors:  T Miyashita; S Nakanuma; A K Ahmed; I Makino; H Hayashi; K Oyama; H Nakagawara; H Tajima; H Takamura; I Ninomiya; S Fushida; J W Harmon; T Ohta
Journal:  Eur Surg       Date:  2015-10-14       Impact factor: 0.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.